Symbol="ACST"
AssetType="Common Stock"
Name="Acasti Pharma Inc"
Description="Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and marketing of prescription drugs for the treatment of cardiovascular disease. The company is headquartered in Laval, Canada."
CIK="1444192"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3009, BOUL. DE LA CONCORDE EAST, SUITE 102, LAVAL, QC, CA"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="18291300"
EBITDA="-18084000"
PERatio="None"
PEGRatio="0"
BookValue="9.14"
DividendPerShare="0"
DividendYield="0"
EPS="-5.72"
RevenuePerShareTTM="0.005"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.11"
ReturnOnEquityTTM="-0.481"
RevenueTTM="115000"
GrossProfitTTM="120000"
DilutedEPSTTM="-5.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="1.99"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="208.39"
PriceToBookRatio="0.157"
EVToRevenue="5.5"
EVToEBITDA="1.037"
Beta="1.451"
num_52WeekHigh="5.94"
num_52WeekLow="2.04"
num_50DayMovingAverage="2.961"
num_200DayMovingAverage="3.094"
SharesOutstanding="7435500"
DividendDate="None"
ExDividendDate="None"
symbol="ACST"
open="2.36"
high="2.48"
low="2.31"
price="2.41"
volume="38465.00"
latest_trading_day="2023-08-08"
previous_close="2.44"
change="-0.03"
change_percent="-1.2295%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="68"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="70704"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="119"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0057.jpeg"
image_negative_thumbnail_id_2="1136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="992"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
